IQVIA Holdings | IQV - Ebitda

Aktienkurs
169.29
Täglich Wechseln
3.65 2.20%
Monatlich
-5.32%
Jährlich
-5.61%
Q1 Prognose
160.67




Ebitda Veränderung Datum
Accenture USD 4.35B 897.45M 2025-12
Agilent USD 540M 74M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 981M 5M 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Cognizant Technology Solutions USD 993M 37M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 135M 32M 2025-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Elevance Health USD 2.19B 1.01B 2025-09
Hologic USD 330.4M 16.6M 2025-12
Humana USD -290M 1.11B 2025-12
IBM USD 6.5B 1.9B 2025-12
Illumina USD 332M 12M 2025-09
Infosys INR 95.1B 10.25B 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 588.1M 24.1M 2025-12
Malin Corporation EUR -1.1M 200K 2024-12
McKesson USD 1.68B 418M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Organigram Holdings CAD 5.26M 884K 2025-12
Pharma Mar EUR 44.96M 46.94M 2025-12
Publicis EUR 1.68B 190M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Tilray USD 8.36M 1.82M 2025-09
UnitedHealth USD 1.5B 3.92B 2025-12
Veeva Systems USD 374.79M 3.96M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06